热门资讯> 正文

ZimVie在美国推出GenTek恢复组件

2024-07-24 00:37

ZimVie (NASDAQ:ZIMV) said it has launched its GenTek Genuine Restorative Components portfolio in the U.S. after receiving market clearance from the FDA.
The GenTek product portfolio has been on the market in Europe since 2019. The products are designed to work with ZimVie’s dental implant systems.

More on ZimVie

ZimVie: Guidance Suggests Company Fairly Valued At The Moment (Rating Downgrade)
ZimVie Inc. (ZIMV) Q1 2024 Earnings Call Transcript
ZimVie jumps after report on buyout talks with South Korea’s Osstem
ZimVie may be worth $25-$29 a share in takeover - analyst
Seeking Alpha’s Quant Rating on ZimVie

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。